Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000. (Q40631426)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 2002

Language	Label	Description	Also known as
English	Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000.	scientific article published on August 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

Clyde Thornsberry

6

object named as

Clyde Thornsberry

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

7

object named as

Daniel F Sahm

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

author name string

Ian A Critchley

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Renée S Blosser-Middleton

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Mark E Jones

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

James A Karlowsky

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Elena A Karginova

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

International Journal of Antimicrobial Agents

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

100-107

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of ciprofloxacin activity against Streptococcus pneumoniae after 10 years of use in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of levofloxacin in the treatment of respiratory tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Benchmarking the in vitro activity of moxifloxacin against recent isolates of Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae. A European multi-centre study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Benchmarking the in vitro activities of moxifloxacin and comparator agents against recent respiratory isolates from 377 medical centers throughout the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Levofloxacin-resistant Streptococcus pneumoniae: second look

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluoroquinolone susceptibility, resistance, and pharmacodynamics versus clinical isolates of Streptococcus pneumoniae from Indiana

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Future of the quinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Quinolones for community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in ciprofloxacin nonsusceptibility and levofloxacin resistance among Streptococcus pneumoniae isolates in North America

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory se

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Will pneumococci put quinolones in their place?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high-level ciprofloxacin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99).

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900125-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0924-8579(02)00125-5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40631426&oldid=2225289031"